Why does Pakistan lag in the use of fibrinolytics in patients with ischemic stroke?
Eastern Mediterranean Health Journal · 03.08.2026 · 32 (7) · 480-481
DOI: 10.26719/2026.32.7.480 ↗Kurz gefasst
Leserbrief in der Zeitschrift Eastern Mediterranean Health Journal, online erschienen am 03.08.2026. Verfasst von Muhammad Ahsan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jinnah Sindh medical University, Karachi, Pakistan.
Themen: Schlaganfall
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jinnah Sindh medical University, Karachi, Pakistan.
- lmam Clinic, Karachi, Pakistan.
- Jinnah Postgraduate Medical Center, Karachi, Pakistan.
Zitieren
APA
Ahsan, M., Janoowala, T., Farooq, T., & Ahmad, A. (2026). Why does Pakistan lag in the use of fibrinolytics in patients with ischemic stroke?. Eastern Mediterranean Health Journal, 32(7), 480-481. https://doi.org/10.26719/2026.32.7.480
Vancouver
Ahsan M, Janoowala T, Farooq T, Ahmad A. Why does Pakistan lag in the use of fibrinolytics in patients with ischemic stroke?. Eastern Mediterranean Health Journal. 2026;32(7):480-481. doi:10.26719/2026.32.7.480
BibTeX
@article{Ahsan2026,
author = {Ahsan, Muhammad and Janoowala, Taher and Farooq, Tehreem and Ahmad, Ali},
title = {Why does Pakistan lag in the use of fibrinolytics in patients with ischemic stroke?},
journal = {Eastern Mediterranean Health Journal},
year = {2026},
volume = {32},
number = {7},
pages = {480--481},
doi = {10.26719/2026.32.7.480}
}
EUVIMED